Clinical Trial

Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn that metformin has effect on motor aspects of daily living and oxidative stress in levodopa treated Parkinson disease patients. Researcher will compare drug metformin to a placebo. Participants will take metformin or placebo for 8 weeks.
Trial Details
NCT Number NCT07055958
Lead Sponsor Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions Parkinson Disease
Enrollment 74 participants
Start Date 2024-12-29
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-07-20 (estimated)
Updated on ClinicalTrials.gov 2025-07-09